Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Influence of Beta Amyloid Imaging on Care of Patients Cognitive Complaints. [NA]
This study evaluated whether beta-amyloid imaging influences care decisions for patients with Alzheimer's disease or mild cognitive impairme…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Pilot Study: Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Prevention [Phase 1, Phase 2]
A Phase 1/2 pilot study evaluating alpha-lipoic acid and omega-3 fatty acids for Alzheimer's prevention has completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients [Phase 3]
This Phase 3 clinical trial evaluated the effects of memantine on brain structure and chemistry in patients with Alzheimer's disease. Result…
-
CLINICAL_TRIALS withdrawal · 2017-04-07Clinical Trial Update: Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease [Phase 2]
Phase 2 safety study of sargramostim for mild cognitive impairment due to Alzheimer's disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Brain Aging Project--Kansas University
The Brain Aging Project trial at University of Kansas Medical Center investigating Alzheimer's disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Neuroimaging Markers of Alzheimer Disease: a Longitudinal Population Study [NA]
A completed longitudinal population study evaluating neuroimaging markers in Alzheimer disease and dementia.
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Effects of a NeuroAD System, for the Treatment of Alzheimer Disease [NA]
The clinical trial evaluating the NeuroAD System for Alzheimer's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Deep Brain Stimulation for the Treatment of Alzheimer's Disease [NA]
A clinical trial sponsored by Ali Rezai evaluating deep brain stimulation for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: ATP in Alzheimer Disease [Phase 2]
A Phase 2 trial evaluating ATP for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose) [Phase 1]
Phase 1 study of NGP-555 in healthy volunteers completed, examining 14-day multiple ascending doses for Alzheimer's disease-related research…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease [NA]
Clinical trial update for light therapy to address sleep/wake disturbances in Alzheimer's disease; study status completed with results poste…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease. [Phase 4]
A Phase 4 study evaluating compliance and tolerability of rivastigmine transdermal patch 10 cm² in patients with probable Alzheimer's diseas…
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil [Phase 2]
Phase 2 study evaluating PF-05212377 versus placebo in Alzheimer's disease patients with neuropsychiatric symptoms on donepezil was terminat…
-
CLINICAL_TRIALS trial_result · 2017-03-17Clinical Trial Update: 18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease [Phase 1]
18-month safety-follow-up results from AADvac1, an active tau vaccine for Alzheimer's disease (Phase 1).
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Pilot Study of Aerobic Exercise in Early Alzheimer's Disease(AD) [NA]
Pilot study assessing aerobic exercise in individuals with early Alzheimer's disease; completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease [Phase 1]
An open-label extension study evaluating safety and tolerability of AAB-003 (PF-05236812) in adults with mild to moderate Alzheimer's diseas…
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Florbetapir Calibration to the Centiloid Scale [Phase 1]
This Phase 1 study evaluates calibration of Florbetapir PET imaging to the Centiloid scale in Alzheimer's disease, with the trial completed …
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease [Phase 1]
Phase 1 study evaluating the PET radioligand [18F]T807 (AV-1451) for imaging tau in Alzheimer's disease has completed. The trial provides in…
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease [Phase 3]
A Phase 3 multicenter, randomized, double-blind, placebo-controlled trial completed to assess the efficacy and safety of donepezil hydrochlo…
-
CLINICAL_TRIALS research · 2017-03-07Clinical Trial Update: A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients
The document provides an update on a completed clinical trial plan to investigate and collect safety information for increasing the Aricept …
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease [Phase 3]
A Phase III clinical trial evaluating nilvadipine for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Therapy of Alzheimer's Disease With Neurofeedback [NA]
The document reports a completed clinical trial from University Hospital Aachen evaluating neurofeedback therapy for Alzheimer's disease in …
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: An Exploratory Study to Compare the Differences in Nutritional Status Between Patients With Mild and Moderate Alzheimer's Disease (AD) and Cognitively Intact Healthy People in an Asian Population
An exploratory study comparing nutritional status between people with mild to moderate Alzheimer's disease and cognitively healthy controls …
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Apoe Impact Study on Brain Structure and Function, in a Population 45 to 75 Years Old
Completed clinical trial examining the impact of ApoE genotype on brain structure and function in adults aged 45-75 with Alzheimer's disease…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Comparative Research of Alzheimer's Disease Drugs [NA]
A comparative study of Alzheimer's disease drugs sponsored by Indiana University was terminated, with results posted on 2017-02-27.